The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
57 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

The Scripps Research Institute (TSRI) is a research and educational organization which conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The organization offers technology and scientific services such as antibody development and production, cell based screening, high performance computing, normal blood donor service and murine behavioral assessment, among others. TSRI also offers education services that include undergraduate, graduate and postdoctoral programs.

The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals inclu

  
Source:
Document ID
GDPH138351D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents25
  List of Tables42
  List of Figures61
The Scripps Research Institute, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201662
The Scripps Research Institute, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201681
The Scripps Research Institute, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201691
The Scripps Research Institute, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016101
The Scripps Research Institute, Medical Devices Deals, 2010 to YTD 2016111
The Scripps Research Institute, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016123
The Scripps Research Institute, Pharmaceuticals &Healthcare, Deal Details1539
  Partnerships151
    Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University151
    Boehringer Ingelheim Enters into Research Agreement with Icahn School of Medicine, Massachusetts General Hospital, Scripps Research Institute and Weill Cornell Medicine162
    Scripps Research Institute, ZIP and IME Enter into Partnership181
    aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery192
    Serina Therapeutics Enters Into Research Agreement With Scripps Research Institute211
    Scripps Research Institute Expands Research Agreement With Takeda221
    Proteostasis Therapeutics Enters Into Co-Development Agreement With Scripps Research Institute232
    Scripps Research Institute Enters Into Research Agreement With Bristol-Myers Squibb251
    ChromaDex Enters Into Co-Development Agreement With Scripps Research Institute261
    Jupiter Medical Center Enters Into Research Agreement With The Scripps Research Institute271
    LEO Pharma Enters Into Research Collaboration With The Scripps Research Institute281
    Molecular Response Enters Into An Agreement With Scripps Translational Science Institute291
    Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University302
    Envoy Therapeutics Expands Its Research Agreement With The Scripps Research Institute321
    Envoy Therapeutics Enters Into Research Collaboration With Scripps Research331
    Sorrento Therapeutics Enters Into Co-Development Agreement With The Scripps Research Institute341
  Licensing Agreements351
    iGenomX Enters into Licensing Agreement with Scripps Research Institute351
    OPKO Health Enters into Licensing Agreement with Scripps Research Institute361
    Corvus Pharma Enters into Licensing Agreement with Scripps Research Institute371
    Padlock Therapeutics Enters into Licensing Agreement with Scripps Research Institute381
    Fabrus Enters into Licensing Agreement with Scripps Research Institute391
    Scripps Research Institute Enters into Licensing Agreement with T23 Biopharma for CD22401
    Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718412
    Sorrento Therapeutics Enters Into Licensing Agreement With Scripps Research Institute431
    Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents442
    Janssen Pharma Enters Into Licensing Agreement With Scripps Research Institute For Infectious Diseases461
    Serina Therapeutics Enters Into License Agreement With Scripps Research Institute For Click Chemistry471
    Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry481
    OPKO Health Enters Into Licensing Agreement With Scripps Research Institute For SR 3306491
    Integrated Diagnostics Enters Into Licensing Agreement With The Scripps Research Institute501
    Optimer Biotech Terminates Licensing Agreement With Scripps Research Institute For OPT-88511
    Scripps Research Enters Into Licensing Agreement With Aileron Therapeutics521
    Allozyne Enters Into Licensing Agreement With The Scripps Research Institute531
The Scripps Research Institute - Key Competitors541
Key Employees551
Locations And Subsidiaries561
  Head Office561
  Other Locations &Subsidiaries561
Appendix571
  Methodology571
  About GlobalData571
  Contact Us571
  Disclaimer571

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-Scripps-Research-Institute-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7729>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-Scripps-Research-Institute-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7729>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research